Pantke, Annemarie
Hoebel, Jens
an der Heiden, Matthias
Michalski, Niels
Gunsenheimer-Bartmeyer, Barbara
Hanke, Kirsten
Bannert, Norbert
Bremer, Viviane
Koppe, Uwe
Funding for this research was provided by:
Robert Koch-Institut
Article History
Received: 18 October 2021
Accepted: 15 February 2022
First Online: 17 March 2022
Declarations
:
: The “InzSurv-HIV” study has been approved by the data protection officer of the Robert Koch Institute and the Federal Commissioner for Data Protection and Freedom of Information (II-401/008#0016). Ethical approval for the monitoring of recent HIV infections was given by the ethics commission at the Charité – Universitätsmedizin Berlin (EA1/007/08). No patient informed consent was obtained as the data on new HIV diagnoses were derived from the national statutory HIV surveillance which is carried out in compliance with the German Infection Protection Act (IfSG). The samples used in the BED-CEIA were residuals from routine diagnostic processing. Recency testing of these samples is only licensed for epidemiological analyses and does not allow for individual patient analyses. All methods used in our study were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.